Volume 16, Number 4—April 2010
Letter
Bartonella spp. Infections, Thailand
Table
Variables | No. (%) Bartonella-infected case-patients,† n = 57 | No. (%) non–case-patients,‡ n = 193 | p value |
---|---|---|---|
Median age, y (range) | 19 (7–72) | 20 (7–79) | 0.9 |
Male sex |
37 (64.9) |
113 (58.5) |
0.4 |
Occupation | |||
Student | 27 (47.4) | 84 (43.5) | 0.6 |
Rice farmer | 20 (35.1) | 40 (20.7) | 0.03 |
Business | 3 (5.3) | 13 (6.7) | 0.7 |
Other§ |
7 (12.3) |
56 (29.0) |
0.01 |
Signs and symptoms | |||
Headache | 44 (77.2) | 161 (83.4) | 0.3 |
Eye pain | 17 (29.8) | 58 (30.1) | 1.0 |
Myalgias | 47 (82.5) | 141 (73.1) | 0.1 |
Extremity pain | 39 (68.4) | 115 (59.6) | 0.2 |
Joint pain | 26 (45.6) | 74 (38.3) | 0.3 |
Vomiting | 22 (38.6) | 80 (41.5) | 0.7 |
Abdominal pain | 12 (21.1) | 64 (33.2) | 0.08 |
Rash | 7 (12.3) | 17 (8.8) | 0.6 |
Lymphadenopathy |
9 (15.8) |
24 (12.4) |
0.5 |
Laboratory results | |||
Anemia (Hb <13 mg/dL) | 30 (60.0) | 93 (50.3) | 0.2 |
Thrombocyte count <100,000/mm3 | 5 (8.9) | 14 (7.4) | 0.7 |
Leukopenia (leukocytes <5,000/mm3) | 10 (17.5) | 63 (32.6) | 0.03 |
Leukocytosis (leukocytes >11,000/mm3) | 20 (35.1) | 33 (17.1) | <0.01 |
Creatinine >1.5 mg/dL | 5 (8.9) | 12 (6.2) | 0.5 |
Bilirubin >1.3 mg/dL | 6 (10.7) | 19 (9.8) | 0.8 |
Alkaline phosphatase >121 IU/L | 36 (64.3) | 132 (68.8) | 0.5 |
AST >36 IU/dL | 18 (32.1) | 88 (45.6) | 0.07 |
ALT >36 IU/dL | 9 (16.1) | 50 (25.9) | 0.1 |
*Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
†Excluded Bartonella-infected patients with serologic evidence of infection with other common pathogens (dengue virus, Leptospira, or Burkholderia pseudomallei; n = 35).
‡Febrile patients with acute-phase and convalescent-phase immunoglobulin G titer against Bartonella species <128.
§Other occupation includes housewife, government officer, day laborer, or construction worker.
Page created: December 23, 2010
Page updated: December 23, 2010
Page reviewed: December 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.